Regardless of sociodemographic or clinical characteristics, children with food allergy face a significant psychosocial burden ...

A groundbreaking Japanese study finds a strong link between newborn gut bacteria and food allergies, suggesting probiotic ...

Significant racial disparities persisted in genetic testing for inborn errors of immunity despite the removal of financial barriers, according to a study published in The Journal of Allergy and ...

AbbVie’s ABBV 2024 revenue grew 4.6% on a constant currency basis, with 2025 guidance of 5.7% growth and new 2027 guidance for combined sales of immunology drug Skyrizi and Rinvoq of $31 billion (up ...

In an increasingly interconnected world, global health faces constant threats from new and re-emerging pathogens. Recent devastating outbreaks of diseases ...

Viruses are masters at disguise. When they are pushed too far by our immune system, they send new virus variants into play ...

AbbVie Inc.'s stock rose 4% early Friday, after the drug company beat fourth-quarter earnings estimates and offered an upbeat view of 2025, as its newer immunology drugs delivered growth needed to ...

A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report today in ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.